MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Home・Aandelen Lijst・Celsion Corp

Celsion Corp

Gesloten

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken
By Trading Economics
Werknemers	25

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+210.88% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	938K
Vorige openingsprijs	0
Vorige sluitingsprijs	0

Celsion Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

9 jan 2026, 22:18 UTC

Marktinformatie

Changes Needed for Exxon Mobil to Return to Venezuela -- Market Talk

9 jan 2026, 21:50 UTC

Marktinformatie

Energy & Utilities Roundup: Market Talk

9 jan 2026, 21:50 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

9 jan 2026, 21:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

9 jan 2026, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

9 jan 2026, 21:43 UTC

Winsten

Acquisities, Fusies, Overnames

These Stocks Moved the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More -- Barrons.com

9 jan 2026, 20:39 UTC

Marktinformatie

GE Vernova Seen With Rising Concern of Overcapacity -- Market Talk

9 jan 2026, 20:38 UTC

Marktinformatie

U.S. Natural Gas Falls on Loose Supply Outlook -- Market Talk

9 jan 2026, 20:36 UTC

Acquisities, Fusies, Overnames

Cathie Wood's ARK Invest Takes a New Stake in Broadcom -- and Sold Another Hot Stock -- Barrons.com

9 jan 2026, 20:30 UTC

Marktinformatie

Oil Makes Weekly Gains in Geopolitically Driven Trade -- Market Talk

9 jan 2026, 20:15 UTC

Marktinformatie

Chevron Seen With Modest Opportunity to Boost Venezuela Oil Production -- Market Talk

9 jan 2026, 20:07 UTC

Marktinformatie

Global Equities Roundup: Market Talk

9 jan 2026, 20:07 UTC

Marktinformatie

Goldman Sachs' Pivot from Consumer Lending Seen as Positive -- Market Talk

9 jan 2026, 19:58 UTC

Acquisities, Fusies, Overnames

Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

9 jan 2026, 19:42 UTC

Marktinformatie

Adobe Seen With Weak Competitive Position Compared to Rivals -- Market Talk

9 jan 2026, 19:38 UTC

Acquisities, Fusies, Overnames

Wolters Kluwer Acquires StandardFusion >WTKWY

9 jan 2026, 19:31 UTC

Winsten

Qualcomm Stock Falls After Downgrade. The Apple Supplier Has an iPhone Problem. -- Barrons.com

9 jan 2026, 19:28 UTC

Winsten

Apple Stock Set to Break Brutal Losing Streak. Why It Remains Evercore's 'Top Pick.' -- Barrons.com

9 jan 2026, 18:30 UTC

Marktinformatie

U.S. Oil Rig Count Falls by 3 to 409 -- Market Talk

9 jan 2026, 18:23 UTC

Marktinformatie

Reports of Canada Oil Sector's Demise Are Premature -- Market Talk

9 jan 2026, 17:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

9 jan 2026, 17:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

9 jan 2026, 17:19 UTC

Marktinformatie

Energy Prices Not Seen Supporting More Drilling -- Market Talk

9 jan 2026, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

9 jan 2026, 17:07 UTC

Marktinformatie

McDonald's Promotions Appear Successful -- Market Talk

9 jan 2026, 17:06 UTC

Marktinformatie

Oil Futures on Track for Weekly Gains -- Market Talk

9 jan 2026, 17:05 UTC

Winsten

Stocks Sail Past Jobs Data, Tariff Opinion Delay. Earnings Season Looms. -- Barrons.com

9 jan 2026, 16:57 UTC

Marktinformatie

Energy Activity Tumbles in 4Q, KC Fed Survey Finds -- Market Talk

9 jan 2026, 16:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

9 jan 2026, 16:46 UTC

Marktinformatie

Dollar Could Stay Steady For Now, More Likely to Fall Than Rise -- Market Talk

Peer Vergelijking

Prijswijziging

Celsion Corp Prognose

Koersdoel

By TipRanks

210.88% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 12 USD 210.88%

Hoogste 12 USD

Laagste 12 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Celsion Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Celsion Corp - Dist in de afgelopen 3 maanden.

Financieel

Over Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.